首页> 外文OA文献 >Evaluation of methodologies for risk assessment of combined toxic actions of chemical substances and establishment of PBTK/TD models for pesticides
【2h】

Evaluation of methodologies for risk assessment of combined toxic actions of chemical substances and establishment of PBTK/TD models for pesticides

机译:评估化学物质联合毒性作用风险评估方法和建立农药pBTK / TD模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Humans are simultaneously exposed to a number of chemicals via food and environment.These chemicals may have a combined action that causes a lower or higher toxic effect thanwould be expected from knowledge about the single compounds. Therefore, combined actionsneed to be addressed in the risk assessment process.This Ph.D.-thesis provides an overview of the current knowledge on methods for riskassessment of combined actions of chemicals focussing on pesticides. Some of the methodsare based on knowledge on the whole mixture and others are based on data on the singlecompounds in the mixture. The whole mixture approaches would be the ideal choice forassessment of e.g. pesticide residues in food. However, they are normally not applicable sincethey require a large number of experimental data that are rarely available. This leaves thesingle compound approaches as the more realistic ones.The first step in the risk assessment of a mixture is to evaluate whether a group of compoundscan be identified that induce a common toxic effect by a common mechanism of toxicity andtherefore is suited for a cumulative risk assessment based on additivity. Ideally theidentification of a group of pesticides for cumulative risk assessment should be based oncriteria providing the best and most robust grouping such as chemical structure, mechanismof action, common toxic mode of action or common toxic effect. Unfortunately, such data areseldom available for all of the compounds of concern. Instead for pragmatic reasons, it is oftenmore appropriate to consider the individual compounds as possible candidates for one (ormore) cumulative assessment group(s).The cumulative risk assessment of this group will then be performed assuming simple similaraction using one of the single compound approaches. The hazard index based on a healthbased guidance value e.g. the acceptable daily intake (ADI) would normally be sufficient.However, the point of departure index is the most preferably method because it does notmake use of a policy driven uncertainty factor and instead it is based on the most relevanttoxicity data.In case that more than one common mechanism group based on different simple similaractions are identified, they should be assessed separately. In addition, the potential forinteractions between the groups (or single compounds) has to be considered. If nointeractions are identified, simple dissimilar action can be anticipated and the responseaddition method should be used to assess the effect of the mixture.In many cases the evaluators will probably tend to use very pragmatic approaches if lack ofinteraction between the compounds at the actual dose level can be assumed. This includesassuming all compounds in the mixture show dose additivity (simple similar actions). Thehazard index or point of departure index would then be the preferred methods.A crucial point in the assessment is whether there is interaction or no interaction between thecompounds in the mixture. Although interactions among chemicals at high doses are wellknown,no single simple approach is currently available to judge upon potential interactionsat the low dose levels of pesticide residues that humans are exposed to in food. For this purpose, physiologically based toxicokinetic/toxicodynamic (PBTK/TD) modelling has beenrecommended as a tool to assess combined tissue doses and to help predict potentialinteractions including thresholds for such effects. Therefore, this thesis also focuses on suchmodels and their applicability for use in risk assessment. This type of model has been used forseveral years in the area of pharmacology but the use in the area of toxicology is relativelynew.In a PBTK model the animal or man is described as a set of tissue compartments which iscombined by mathematical descriptions of biological tissues and physiological processes inthe body. Thereby it is possible to quantitatively simulate the absorption, distribution,metabolism and excretion of chemicals and to predict the internal dose after exposure to thechemical (or metabolite) of concern.The PBTK models make it possible to extrapolate between species, from high-dose to lowdose,from route-to-route and between exposure scenarios. In this way the risk assessor cansimulate various scenarios including scenarios which cannot be studied experimentally.Models can be developed for subpopulations such as children and this may help the riskassessor determine whether special care should be taken for such groups.It is also possible to incorporate mechanistic information on interactions in the model and asmentioned above interaction threshold can be determined. This would provide a helpful toolin the risk assessment of combined actions of chemicals.The PBTK model can be coupled with a toxicodynamic part in which the model attempts toestimate the effect resulting from the internal dose. The output of a PBTK model is linked to atoxicodynamic model by mathematical descriptions of the hypothesis of how compoundscontribute to the initiation of cellular changes leading to the toxic responses.In the present Ph.D. project a PBTK/TD model was established based on a previous publishedmodel. The model describes the organophosphorus pesticide chlorpyrifos and its metabolismto chlorpyrifos-oxon and 3,5,6-trichloro-2-pyridinol as well as the toxicodynamic of thechlorpyrifos-oxon i.e. inhibition of acetylcholinesterase activity in various tissues. This paperwas chosen because the model is on a relevant compound (a pesticide that is widely used) andone had the impression that the model work was described in details.The work in establishing this model clearly pointed out the importance that authors of suchpublications report their results with a high degree of transparency in order to enablecolleagues to reproduce their work and e.g. evaluate it for further developing the model. Themodel description should include model structure and equations as well as documentation ofthe choice of parameters and their origin. At present there is a lack of adequate data for use inthe PBTK models and further studies in order to determine parameters for use in PBTKmodels are needed. The model developer is also forced to make assumptions andextrapolations. It is of great importance that these are biologically based and explained.The PBTK/TD model on chlorpyrifos in the present project was used to illustrate how a noobserved adverse effect level (NOAEL) can be established by the model and how to makeextrapolations between species (rats and humans). The model underestimated the inhibition improvement before it can be used in risk assessment.The PBTD modelling is still in its infancy and it will probably be better to put more effort intoimproving the toxicokinetic part especially including establishment of internationallyacceptable reference values for various parameters before extending the model with atoxicodynamic part.PBTK models can be used to evaluate combined actions of a mixture of compounds. In case ofa mixture of compounds that do not interact (e.g. simple similar action) the PBTK modellingtool is useful to predict the combined doses in the target organ taking metabolism of thecompounds into account. Such compounds should be dealt with in the PBTK models in thesame way as single compounds.In case of a mixture of interacting compounds mechanistic information on interactions can beincorporated in the PBTK/TD model and thereby it can be used e.g. to determine theinteraction threshold. Such a model will consists of sets of identical equations, one set for eachchemical as well as equations that specifically accounts for the interactions (e.g. competitiveinhibition of metabolism in liver or induction of hepatic metabolism).The development of PBTK models is complex and should only be used when it is consideredessential. If adequate models are developed, they can provide better knowledge andunderstanding of the effects of mixtures in the organism and provide improved informationon tissue dose levels and variations between species and within a population. Moreover,scientifically supportable results about possible combined actions in humans after exposureto mixtures of pesticide residues in food would help making more reliable risk assessment.The PBTK models thus have a potential as an important tool in the risk assessment. Adequatedocumentation of the model is fundamental in order to increase the credibility of PBTKmodelling. Such credibility is crucial for a spreading of its use in risk assessment.This Ph.D.-project constitutes the initial work on implementing PBTK/TD models in the riskassessment of combined toxic action of chemical substances in food at the DTU National FoodInstitute. The work has revealed some major problems and pitfalls in the developing process.However if reliable, these models will provide knowledge of the relationship between internaldoses of the chemicals and the observed toxic effects and this knowledge will reduce theuncertainty in the risk assessment. Therefore, the work will continue implementing thesemodels as a helpful tool in future risk assessment.
机译:人类同时通过食物和环境暴露于多种化学物质中。这些化学物质可能具有共同的作用,其毒性作用可能比对单一化合物的了解所预期的低或高。因此,在风险评估过程中需要考虑采取联合行动。本博士论文概述了有关以农药为重点的化学物质联合行动的风险评估方法的最新知识。一些方法基于整个混合物的知识,而另一些方法则基于混合物中单个化合物的数据。整个混合方法将是评估诸如食物中的农药残留。但是,它们通常不适用,因为它们需要大量很少可用的实验数据。这使得单一化合物方法更为现实。混合物风险评估的第一步是评估是否可以通过共同的毒性机制鉴定出一组化合物,这些化合物通过共同的毒性机理引起共同的毒性作用,因此适合累积风险。基于可加性的评估。理想情况下,应根据提供最佳和最可靠分类的标准(例如化学结构,作用机理,常见的毒性作用方式或常见的毒性作用)来鉴定用于累积风险评估的一组农药。不幸的是,这些数据很少可用于所有关注的化合物。出于务实的考虑,通常更适合将单个化合物视为一个(或多个)累积评估组的候选者。然后使用一种单一化合物方法中的简单相似假设,对该组进行累积风险评估。 。基于健康指导值的危害指数,例如通常,可接受的每日摄入量(ADI)就足够了。但是,出发点指数是最优选的方法,因为它不使用政策驱动的不确定性因素,而是基于最相关的毒性数据。而不是根据不同的简单相似作用识别出一个共同的机制组,则应分别进行评估。另外,必须考虑基团(或单一化合物)之间相互作用的可能性。如果未发现相互作用,则可以预见简单的不同作用,应使用响应加法评估混合物的效果。在许多情况下,如果化合物之间在实际剂量水平上缺乏相互作用,则评价者可能倾向于使用非常实用的方法。可以假设。这包括假设混合物中的所有化合物均显示出剂量加和(简单的相似作用)。危险指数或出发点指数将是首选方法。评估的关键点是混合物中化合物之间是否存在相互作用。尽管高剂量化学物质之间的相互作用是众所周知的,但目前尚没有一种简单的方法可以判断人在食物中所接触农药的低剂量水平下的潜在相互作用。为了这个目的,已经推荐基于生理学的毒物动力学/毒物动力学(PBTK / TD)建模作为评估组合组织剂量并帮助预测潜在相互作用的工具,包括这种作用的阈值。因此,本文还着重研究了此类模型及其在风险评估中的适用性。这种类型的模型在药理学领域已经使用了数年,但在毒理学领域的应用却相对较新。在PBTK模型中,动物或人被描述为一组组织隔室,通过对生物组织和体内的生理过程。因此,可以定量地模拟化学物质的吸收,分布,代谢和排泄,并预测暴露于所关注的化学物质(或代谢产物)后的内部剂量。PBTK模型使从高剂量到高剂量的物种间推断成为可能。低剂量,从路线到路线以及暴露场景之间。通过这种方式,风险评估者可以模拟各种无法通过实验研究的情景,可以为诸如儿童这样的亚人群开发模型,这可以帮助风险评估者确定是否应该对此类人群采取特殊的照顾措施。可以确定关于模型中的相互作用的信息以及如上所述的相互作用阈值。 PBTK模型可以与毒理动力学部分结合使用,在该模型中,该模型试图评估内部剂量所产生的影响。 PBTK模型的输出通过对化合物如何促进细胞变化引发毒性反应的假设的数学描述与无毒物动力学模型联系起来。在一个项目中,基于先前发布的模型建立了PBTK / TD模型。该模型描述了有机磷农药毒死rif及其代谢成毒死ox和3,5,6-三氯-2-吡啶醇以及毒死rif的毒性,即抑制了各种组织中的乙酰胆碱酯酶活性。选择该模型的原因是该模型基于相关化合物(广泛使用的农药),并且给人的印象是对模型工作进行了详细描述。建立模型的工作明确指出了此类出版物的作者报告其结果的重要性具有高度的透明度,以使同事能够重现他们的工作,例如对其进行评估以进一步开发模型。模型说明应包括模型结构和方程式,以及有关参数选择及其来源的文档。目前,尚缺乏足够的数据可用于PBTK模型,需要进一步研究以确定用于PBTK模型的参数。模型开发人员还被迫进行假设和推断。这些是生物学基础并加以解释是非常重要的。本项目中毒死rif的PBTK / TD模型用于说明该模型如何建立未观察到的不良反应水平(NOAEL)以及如何在物种之间进行外推(大鼠和人类)。在将其用于风险评估之前,该模型低估了抑制作用的改善。PBTD模型仍处于起步阶段,可能最好将更多的精力投入到改善毒物代谢动力学方面,尤其包括在扩展检测范围之前建立各种参数的国际可接受的参考值。 PBTK模型可用于评估化合物混合物的联合作用。在没有相互作用的化合物的混合物的情况下(例如简单的相似作用),PBTK建模工具可用于在考虑化合物代谢的情况下预测靶器官中的联合剂量。此类化合物应以与单一化合物相同的方式处理在PBTK模型中。如果发生相互作用的化合物混合,则可以将有关相互作用的机理信息纳入PBTK / TD模型中,从而可以将其用于例如确定相互作用阈值。这种模型将由一组相同的方程组,一组针对每种化学物质的方程组以及专门考虑相互作用的方程组(例如,肝脏中新陈代谢的竞争性抑制或肝新陈代谢的诱导)。在认为必要时使用。如果开发出足够的模型,它们可以提供更好的知识和对混合物在生物体中作用的了解,并提供有关组织剂量水平以及物种之间和种群内变化的信息。此外,有关食品中农药残留混合物暴露于人体后可能的联合作用的科学支持性结果将有助于进行更可靠的风险评估。因此,PBTK模型具有作为风险评估中重要工具的潜力。为了增加PBTK模型的可信度,该模型的充分文献资料至关重要。这种信誉对于在风险评估中的广泛应用至关重要。该博士项目是在DTU国家食品研究所对食品中化学物质的综合毒性作用进行风险评估时实施PBTK / TD模型的初步工作。这项工作揭示了开发过程中的一些主要问题和陷阱。但是,如果这些模型可靠,它们将提供有关化学品内部剂量与所观察到的毒性作用之间关系的知识,并且这种知识将减少风险评估中的不确定性。因此,这项工作将继续实施这些模型,作为将来进行风险评估的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号